Overview

Dose Finding Study to Determine if BEZ235 Alone or in Combination With RAD001 Decreases the Incidence of Respiratory Tract Infections in the Elderly

Status:
Active, not recruiting

Trial end date:
2018-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy, tolerability, and safety of BEZ235 alone and in combination with RAD001 to support further development to reduce the incidence of respiratory tract infections (RTIs) in elderly subjects.

Phase:

Phase 2

Details

Lead Sponsor:

Restorbio Inc.

Treatments:

Dactolisib
Everolimus